Dual time point [18F]Flurodeoxyglucose (FDG) Positron Emission Tomography (PET)/Computed Tomography (CT) with water gastric distension in differentiation between malignant and benign gastric lesions

被引:1
|
作者
Farghaly, Hussein [1 ,2 ]
Alshareef, Mohamed [2 ]
Alqarni, Abdullah [2 ]
Sayed, Mohamed [1 ]
Nasr, Hatem [2 ,3 ]
机构
[1] Assiut Univ, Fac Med, Dept Oncol & Nucl Med, Assiut, Egypt
[2] Prince Sultan Mil Med City, Dept Radiol, Riyadh, Saudi Arabia
[3] Cairo Univ, Fac Med, Dept Oncol & Nucl Med, Cairo, Egypt
关键词
18F]Flurodeoxyglucose positron emission tomography/Computed tomography (F-18 FDG PET/CT); Dual time point imaging; Gastric malignancy; Water gastric distension; F-18-FDG PET; ORAL CONTRAST; FOLLOW-UP; CANCER; DIAGNOSIS; STOMACH; PITFALLS; EXPRESSION; CARCINOMA; TUMOR;
D O I
10.1016/j.ejro.2020.100268
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objectives: To assess diagnostic accuracy and added value of dual time point F-18-FDG PET/CT after gastric distention using oral water in differentiating malignant from benign gastric lesions. Methods: Patients (n = 30, 19 males, mean age 58.6 +/- 16.4 years). All patients are known or suspected oncology patients. All patients underwent whole body F-18-FDG PET/CT scan and 2 h delayed PET/CT abdominal images following oral water gastric distension. The best cut off values for early SUVmax (SUVmax1), delayed SUVmax (SUVmax2) and SUVmax2-SUVmax1 (Delta SUVmax) to differentiate benign from malignant lesions were set based on ROC analysis. Data analyzed included in addition; age, sex and F-18-FDG uptake pattern in delayed images. Suspicious gastric lesions were correlated with biopsy in 18 patients (60 %) and with clinical and follow-up imaging (F-18-FDG PET/CT, CT or MRI) in 12 patients (40 %). Unpaired t-test was used to compare the mean deference in continuous variables between patients with gastric malignancy and those with benign gastric lesions. Fisher's exact test was used to analyze categorical variables. Logistic regression analysis was performed to identify the most powerful factors to predict malignant lesions. Results: Fifteen patients (50 %) had confirmed malignant gastric lesions. Patients with confirmed gastric malignancy were older (65 +/- 13 vs 52 +/- 17; p = 0.023) and had significantly higher mean Delta SUVmax (1.29 +/- 1.76 vs 0.89 +/- 1.59; p = 0.003). The mean SUVmax1 (6.99 +/- 6.66 vs 5.31 +/- 2.53; p = 0.367) and SUVmax2 (8.29 +/- 7.41 vs 4.44 +/- 3.34; p = 0.077) although both higher in patients with malignant lesions, they did not reach statistical significance. Sensitivity, specificity, PPV, NPV, and accuracy to detect malignant gastric lesions were highest for lesions with localized uptake pattern in delayed images post water oral contrast as well as for lesions with Delta SUVmax>0. Regression analysis revealed both variables as independent predictors for malignant lesions with odd ratios of 22.9 and 9.5 respectively and final model Chi-Square of 19.9 (p < 0.0001). The model correctly identified 12/15 (80 %) malignant lesions and 13/15 (86.7 %) benign lesions with 2 false positives confirmed as chronic active gastritis with helicobacter pylori and 3 false negatives including 1 signet ring gastric cancer and 1 low grade gastrointestinal stromal tumor (GIST), both with poor 18 F-FDG uptake. Conclusion: Localized uptake pattern in delayed PET/CT images following gastric distention with oral water contrast as well as Delta SUVmax>0 are powerful independent variables to identify malignant gastric lesions with fairly high sensitivity and reasonable accuracy. Malignancies with inherently low F-18-FDG avidity are the main cause of false negatives while active gastritis is the main cause of false positives.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Case series-18F-DCFPyL-positron emission tomography/computed tomography (PET/CT) time of imaging
    Sistani, Golmehr
    Metser, Ur
    Bauman, Glenn S.
    Laidley, David T.
    Pautler, Stephen E.
    Zukotynski, Katherine A.
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2021, 15 (07): : E376 - E379
  • [42] The Role of 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) in the Diagnosis and Evaluation of Spondylodiscitis
    Paez, Diana
    Giammarile, Francesco
    Brink, Anita
    Garcia-Perez, Osvaldo
    Estrada-Lobato, Enrique
    SEMINARS IN NUCLEAR MEDICINE, 2024, 54 (03) : 409 - 414
  • [43] Comparision between (18F) fluorodeoxyglucose positron emission tomography (FDG-PET) and computed tomography scan (CT scan) in the staging of patients with untreated follicular lymphoma (FL)
    Vigliotti, M. L.
    Cascini, G.
    De Chiara, A.
    D'Arena, G.
    Corazzelli, G.
    Frigeri, F.
    Marcacci, G.
    Della Cioppa, P.
    Oliviero, F.
    Franco, R.
    La Storia, S.
    Pinto, A.
    ANNALS OF ONCOLOGY, 2005, 16 : 58 - 58
  • [44] Utility of 18-Flurodeoxyglucose Positron Emission Tomography-Computed Tomography ( 18 FDG PET-CT) in Gallbladder Cancer: Experience from a Tertiary Care Hospital
    Bisht, Niharika
    Lohia, Nishant
    Singh, Sankalp
    Sarin, Arti
    Mahato, Abhishek
    Paliwal, Dharmesh
    Sinha, Indranil
    Bhatnagar, Sharad
    WORLD JOURNAL OF NUCLEAR MEDICINE, 2023, 22 (04) : 276 - 283
  • [45] Is there a role for [18F]2-fluoro-2-deoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in predicting radiation pneumonitis
    Song, H.
    Yu, J.
    Lu, J.
    Bai, T.
    Ma, L.
    Fu, Z.
    Kong, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S691 - S691
  • [46] Differentiation between malignant and benign pathologic fractures with F-18-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography
    Shin, D. -S.
    Shon, O. -J.
    Byun, S. -J.
    Choi, J. -H.
    Chun, K. -A.
    Cho, I. -H.
    SKELETAL RADIOLOGY, 2008, 37 (05) : 415 - 421
  • [47] Differentiation between malignant and benign pathologic fractures with F-18-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography
    D.-S. Shin
    O.-J. Shon
    S.-J. Byun
    J.-H. Choi
    K.-A. Chun
    I.-H. Cho
    Skeletal Radiology, 2008, 37 : 415 - 421
  • [48] 18F-FDG Positron Emission Tomography/Computed Tomography (PET/CT) for Distinguishing Tuberous Sclerosis Complex Lesions from Colon Cancer Metastases
    Mazurek, Andrzej
    Dziuk, Miroslaw
    Witkowska-Patena, Ewa
    Gizewska, Agnieszka
    Piszczek, Stanislaw
    AMERICAN JOURNAL OF CASE REPORTS, 2021, 22
  • [49] ROLE OF 18F-FLUORODEOXY GLUCOSE POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY (18F-FDG PET-CT) IN THE EVALUATION OF PANCREATIC CYSTIC LESIONS
    Chandan, Peddapulla
    Rana, Surinder S.
    Sharma, Ravi K.
    Gupta, Rajesh
    Kang, Mandeep
    Nada, Ritambhra
    Srinivasan, Radhika
    Mittal, B. R.
    GASTROENTEROLOGY, 2018, 154 (06) : S942 - S942
  • [50] Adenoid Cystic Carcinoma of Trachea: Findings on 18F FDG Positron Emission Tomography-Computed Tomography
    Tripathy, Sarthak
    Shamim, Shamim Ahmed
    Behera, Abhishek
    Bal, Chandrasekhar
    Kumar, Rakesh
    INDIAN JOURNAL OF NUCLEAR MEDICINE, 2019, 34 (03): : 249 - 250